GlassScriptPhysician profile
Holly B Hahn
NPI 1023125994
$2,835.29
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $247 · 2021: $177 · 2022: $451 · 2023: $966 · 2024: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $819.67 | 2019-2024 | |
| Arcutis Biotherapeutics, INC. | $514.82 | 2023-2024 | Zoryve |
| Novartis Pharmaceuticals Corporation | $220.00 | 2019-2020 | |
| Lilly USA, LLC | $189.44 | 2019-2024 | Olumiant, Taltz |
| Genentech USA, INC. | $173.54 | 2019-2020 | |
| Janssen Biotech, INC. | $153.05 | 2019-2023 | Tremfya, Simponi, Simponi Aria |
| Pfizer INC. | $132.57 | 2021-2023 | |
| Janssen Scientific Affairs, LLC | $109.99 | 2019 | |
| Dermira, INC. | $97.02 | 2019 | |
| Genzyme Corporation | $84.30 | 2023 | |
| Celgene Corporation | $81.09 | 2019 | |
| Dermavant Sciences, INC. | $72.09 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $53.40 | 2022-2023 | Winlevi, Absorica Ld |
| Leo Pharma INC. | $50.00 | 2019 | |
| Vyne Pharmaceuticals INC. | $40.47 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $19.16 | 2022 | |
| Almirall LLC | $12.65 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.